Welcome

Why “waiting to decide” quietly beats technical risk as the #1 value destroyer (and what to do about it in upcoming decade?) Pharma loves to debate technical risk : assay robustness, scale-up, stability, comparability, clinical endpoints, validation strategy. All real. But the risk that quietly outperforms all of those—year after year—is decision latency : the time between when the organization has enough information to decide and when it actually commits . Decision latency